Shares of Sage Therapeutics Inc. surged after Biogen Inc. offered to acquire the neuroscience-focused drugmaker for about $469 million.
Sage Therapeutics Jumps on Biogen’s $469 Million Takeover Offer
Estimated read time
1 min read
You May Also Like
More From Author
Rare comet may be visible for only time in 160,000 years
January 13, 2025
This Crystal-Infused Serum Adds Radiance and Minimizes Wrinkles
January 13, 2025
+ There are no comments
Add yours